Replaces Prod. #: BML-P410
Highly specific, potent and reversible inhibitor of caspase-3. Ki<1nM for purified caspase-3. IC50=0.2nM for PARP cleavage in cultured human osteosarcoma cell extracts. In contrast, the caspase-1 (ICE) specific inhibitor YVAD-CHO has a Ki=12µM for caspase-3 and IC50>10µM for PARP cleavage in osteosarcoma cell extracts. The DEVD sequence is based on PARP cleavage site Asp-216 for caspase-3.
Product Details
| Alternative Name: | Caspase-3 inhibitor (aldehyde), Caspase-7 inhibitor (aldehyde) |
| |
| Sequence: | Ac-Asp-Glu-Val-Asp-CHO |
| |
| Formula: | C20H30N4O11 |
| |
| MW: | 502.5 |
| |
| CAS: | 169332-60-9 |
| |
| Formulation: | Lyophilized. |
| |
| Peptide Content: | 70-90%. |
| |
| Purity: | ≥95% (HPLC) |
| |
| Solubility: | Soluble in distilled water or DMSO. |
| |
| Reconstitution: | Add 0.2ml DMSO per 1mg peptide. Shake well until all the contents are dissolved. This furnishes a 10mM solution of this material. |
| |
| Shipping: | Ambient Temperature |
| |
| Long Term Storage: | -20°C |
| |
| Use/Stability: | Stock solutions should be divided into aliquots and stored at -20°C. Solutions are stable for at least 1 month when stored at -20°C in the dark and protected from moisture. |
| |
| Handling: | Keep under nitrogen. Keep cool and dry. |
| |
| Regulatory Status: | RUO - Research Use Only |
| |
Product Literature References
Hydrogen Peroxide Is Crucial for NLRP3 Inflammasome-Mediated IL-1β Production and Cell Death in Pneumococcal Infections of Bronchial Epithelial Cells; Journal of Innate Immunity: S. Surabhi, et al.; J. Innate Immun.
10, 1159 (2021),
Abstract;
Promoted "Click" SERS Detection for Precise Intracellular Imaging of Caspase-3: W. Zhu, et al.; Anal. Chem.
93, 4876 (2021),
Abstract;
Activation of NLRP3 by uropathogenic Escherichia coli is associated with IL-1β release and regulation of antimicrobial properties in human neutrophils: I. Demirel, et al.; Sci. Rep.
10, 21837 (2020),
Abstract;
Full Text
The Therapeutic Value of SC66 in Human Renal Cell Carcinoma Cells: M. Xu, et al.; Cell Death Dis.
11, 353 (2020),
Abstract;
Full Text
Curcumin differentially affects cell cycle and cell death in acute and chronic myeloid leukemia cells: M. Martinez-Castillo, et al.; Oncol. Lett.
15, 6777 (2018),
Abstract;
Full Text
Caspase-6 Undergoes a Distinct Helix-Strand Interconversion upon Substrate Binding: K.B. Dagbay, et al.; J. Biol. Chem.
292, 4885 (2017),
Abstract;
Full Text
Albumin-binding caspase-cleavable prodrug that is selectively activated in radiation exposed local tumor: S.W. Chung, et al.; Biomaterials
94, 1 (2016),
Application(s): Cell culture,
Abstract;
Diclofenac induces proteasome and mitochondrial dysfunction in murine cardiomyocytes and hearts: R. Ghosh, et al.; Int. J. Cardiol.
223, 923 (2016),
Application(s): Measurement of Caspase 3 activity - mouse heart, liver, and kidney,
Abstract;
MicroRNAs in Hyperglycemia Induced Endothelial Cell Dysfunction: M. Silambarasan, et al.; Int. J. Mol. Sci.
17, 518 (2016),
Application(s): Cell culture,
Abstract;
Full Text
Differential apoptosis-related protein expression, mitochondrial properties, proteolytic enzyme activity, and DNA fragmentation between skeletal muscles: E.M. McMillan, et al.; Am. J. Physiol. Regul. Integr. Comp. Physiol.
300, R531 (2011),
Abstract;
Full Text
Inhibition of ubiquitin-proteasome pathway activates a caspase-3-like protease and induces Bcl-2 cleavage in human M-07e leukaemic cells: X.M. Zhang, et al.; Biochem. J.
340, 127 (1999),
Abstract;
Full Text
Interferon gamma induces upregulation and activation of caspases 1, 3, and 8 to produce apoptosis in human erythroid progenitor cells: C. Dai & S.B. Krantz; Blood
93, 3309 (1999),
Abstract;
Inhibition of human caspases by peptide-based and macromolecular inhibitors: M. Garcia-Calvo, et al.; J. Biol. Chem.
273, 32608 (1998),
Abstract;
Full Text
A sequential two-step mechanism for the production of the mature p17:p12 form of caspase-3 in vitro: Z. Han, et al.; J. Biol. Chem.
272, 13432 (1997),
Abstract;
Full Text
CPP32/apopain is a key interleukin 1 beta converting enzyme-like protease involved in Fas-mediated apoptosis: J. Schlegel, et al.; J. Biol. Chem.
271, 1841 (1996),
Abstract;
Full Text
ICE/CED3-like proteases as therapeutic targets for the control of inappropriate apoptosis: D.W. Nicholson; Nature Biotechnol.
14, 297 (1996),
Abstract;
Sequential activation of ICE-like and CPP32-like proteases during Fas- mediated apoptosis: M. Enari, et al.; Nature
380, 723 (1996),
Abstract;
Identification and inhibition of the ICE/CED-3 protease necessary for mammalian apoptosis: D.W. Nicholson, et al.; Nature
376, 37 (1995),
Abstract;
Cleavage of poly(ADP-ribose) polymerase by a proteinase with properties like ICE: Y.A. Lazebnik et al.; Nature
371, 346 (1994),
Abstract;
